Know Cancer

or
forgot password

    • cancer clinical trials in peabody, MA

    • Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    NSMC Cancer Center
    Peabody, Massachusetts 01960
    Prostate Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    NSMC Cancer Center - Peabody
    Peabody, Massachusetts 01960
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer
    NSMC Cancer Center - Peabody
    Peabody, Massachusetts 01960
    Chemotherapeutic Agent Toxicity, Head and Neck Cancer, Mucositis, Radiation Toxicity, Xerostomia
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    NSMC Cancer Center - Peabody
    Peabody, Massachusetts 01960
    Prostate Cancer
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    NSMC Cancer Center - Peabody
    Peabody, Massachusetts 01960
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    NSMC Cancer Center - Peabody
    Peabody, Massachusetts 01960
    Head and Neck Cancer, Precancerous Condition
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    NSMC Cancer Center
    Peabody, Massachusetts 01960
    Anemia, Head and Neck Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    NSMC Cancer Center
    Peabody, Massachusetts 01960
    Carcinoma of Unknown Primary
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    NSMC Cancer Center - Peabody
    Peabody, Massachusetts 01960
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
    North Shore Medical Center Cancer Center
    Peabody, Massachusetts 01960
    Esophageal Cancer, Gastric Cancer, Neoplasm Metastasis
    Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
    North Shore Cancer Center
    Peabody, Massachusetts 01960
    Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    North Shore Medical Cancer Center
    Peabody, Massachusetts 01960
    Breast Neoplasms, Neoplasm Metastasis
    A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
    Site Reference ID/Investigator# 3793
    Peabody, Massachusetts 01960
    Lung Cancer, NSCLC, Non-Small-Cell Lung Cancer